lysergic acid diethylamide has been researched along with psilocybin in 320 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 163 (50.94) | 18.7374 |
| 1990's | 2 (0.63) | 18.2507 |
| 2000's | 12 (3.75) | 29.6817 |
| 2010's | 37 (11.56) | 24.3611 |
| 2020's | 106 (33.13) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, LJ | 1 |
| Sicuteri, F | 1 |
| Fingerman, M; Rao, KR | 1 |
| Gillin, JC; Kleinman, JE; Wyatt, RJ | 1 |
| Christoph, GR; Jacobs, BL; Stark, AD; Trulson, ME | 1 |
| Gebhart, E | 1 |
| Mace, S | 1 |
| Clark, WG; Masuoka, DT; Menon, MK | 1 |
| Bright, LD; Martin, WR; Morton, EC; Nozaki, M; Vaupel, DB | 1 |
| Van Went, GF | 1 |
| Gruszczyński, W; Rydzyński, Z | 1 |
| Logan, WJ | 1 |
| Brown, JK; Malone, MH | 2 |
| Jacobs, BL; Stern, WC; Trulson, ME | 1 |
| Appel, JB; Kuhn, DM; White, FJ | 1 |
| Aghajanian, GK; Hailgler, HJ | 1 |
| Haddad, LM | 1 |
| Grant, I; Mohns, L | 1 |
| Appel, JB; Cameron, OG | 2 |
| Buckholtz, NS; Freedman, DX; Potter, WZ; Zhou, DF | 1 |
| Schwartz, RH; Smith, DE | 1 |
| Braden, NJ; Brown, RT | 1 |
| Leonard, HL; Rapoport, JL | 1 |
| Meldrum, BS; Naquet, R | 2 |
| Appel, JB; Greenberg, I; Kuhn, DM | 1 |
| Heimann, H | 1 |
| Bermond, F; Bert, J | 1 |
| Eberle, P | 1 |
| Anselmi, B; Del Bianco, PL; Sicuteri, F | 1 |
| Ladefoged, O | 2 |
| Schaub, E; Waser, PG | 1 |
| Andén, NE | 1 |
| Dyer, DC; Gant, DW | 1 |
| Haefely, W | 1 |
| Vinar, O | 1 |
| Kochansky, GE; Lieff, J; Salzman, C; Shader, RI | 1 |
| Fanciullacci, M; Franchi, G; Sicuteri, F | 1 |
| Nair, X | 1 |
| Aaron, JJ; Sanders, LB; Winefordner, JD | 1 |
| Berthod, H; Courrière, P; Pullman, B | 1 |
| Rougeul, A; Verdeaux, J | 1 |
| Sperling, A | 1 |
| Consroe, PF | 1 |
| Brimblecombe, RW | 1 |
| Brown, JK; Griffin, GD; Shapazian, L | 1 |
| Brawley, P; Duffield, JC | 1 |
| Bernik, V | 1 |
| Baker, RW; Chothia, C; Pauling, P; Weber, HP | 1 |
| Kugler, J | 1 |
| Lavenhar, MA; Sheffet, A | 1 |
| Green, JP; Johnson, CL; Kang, S | 1 |
| Barchas, JD; Boggan, W; Freedman, DX; Goldstein, M; Stolk, JM | 1 |
| Faillace, L; Hollister, L; Snyder, SH | 1 |
| Rysánek, K; Vítek, V; Vojtĕchovský, M | 1 |
| Kieffer, SN; Moritz, TB | 1 |
| Kieffer, SN; Mortiz, TB | 1 |
| Hole, G | 2 |
| Farnsworth, NR | 1 |
| Pahnke, WN | 1 |
| Herman, Z; Nowak, S | 1 |
| Rysánek, K | 1 |
| Kanzler, M; Malitz, S | 1 |
| Leuner, H | 5 |
| Klug, E | 1 |
| Witt, PN | 1 |
| Buckman, J | 1 |
| Shibuya, K | 1 |
| Rosecrans, JA; Schechter, MD | 1 |
| Peterson, GC; Wilson, MR | 1 |
| Waser, PG | 1 |
| Fuxe, K; Meek, JL | 1 |
| Fischer, R; Hill, RM; Warshay, D | 1 |
| Geert-Jörgensen, E | 1 |
| Jorgensen, F | 1 |
| Farrow, JT; Gjika, HB; Levine, L; Van Vunakis, H | 1 |
| Barnes, DT | 1 |
| Seal, RE | 1 |
| Lewis, JJ; Ritchie, AP; van Petten, GR | 1 |
| Corne, SJ; Pickering, RW | 1 |
| Eades, CG; Martin, WR | 1 |
| Larin, F; Shein, HM; Wilson, S; Wurtman, RJ | 1 |
| Abramson, HA; Rolo, A | 1 |
| Taber, WA | 1 |
| Kaij, L | 1 |
| Letalle, A; Rougeul, A; Verdeaux, J | 1 |
| Knoll, B; Knoll, J; Vizi, ES | 1 |
| Cheek, FE; Joffe, M; Newell, S | 1 |
| Fisher, G | 1 |
| Gutnick, MJ; Scholes, NW | 1 |
| Monti, A | 1 |
| Ginestet, D | 1 |
| Cerletti, A; Taeschler, M; Weidmann, H | 1 |
| Heim, E; Heimann, H; Lukács, G | 1 |
| Appel, JB; Freedman, DX | 1 |
| Schneider, C | 1 |
| Cwynar, S; Grzelak, L; Jagiello, W; Rydzyński, Z | 1 |
| Jenny, E; Solberg, R | 1 |
| Louria, DB | 1 |
| Sugrue, MF | 1 |
| Fischer, R | 1 |
| Kemper, F | 1 |
| Hollister, LE; Sjoberg, BM | 2 |
| Retterstol, N | 1 |
| Uyeno, ET | 3 |
| Barkema, PR; Kappers, J; van Asperen de Boer, SR | 1 |
| Polvan, O | 1 |
| Fischer, R; Hebbard, FW | 1 |
| Nakajima, H; Thuillier, J | 1 |
| Marchbanks, RM | 1 |
| Cohen, S | 1 |
| Fairchild, MD; Jenden, DJ; Mickey, MR; Yale, C | 1 |
| Järbe, TU | 1 |
| Heym, J; Jacobs, BL; Trulson, ME | 1 |
| Halaris, AE | 1 |
| Appel, JB; Koerner, J | 1 |
| DiSclafani, A; Gardner, ER; Hall, RC | 1 |
| Aghajanian, GK; McCall, RB | 1 |
| Vollenweider, FX | 1 |
| Ghuran, A; Nolan, J | 1 |
| DELAY, J; DURANDIN, MC; NAKAJIMA, H; THUILLIER, J | 1 |
| ISBELL, H; MINER, EJ; WIKLER, A; WOLBACH, AB | 1 |
| BAKKER, C; FEUERFILE, DF; POLLARD, JC; UHR, L | 1 |
| ADEY, WR; BELL, FR; DENNIS, BJ | 1 |
| HOLFELD, H | 1 |
| HARTMAN, AM; HOLLISTER, LE | 2 |
| UNGER, SM | 1 |
| ISBELL, H; MINER, EJ; WOLBACH, AB | 1 |
| ALDAHEFF, BW | 1 |
| CALANCA, A | 1 |
| ABRAMSON, HA; DEAN, G; GETTNER, HH; ROLO, A | 1 |
| CHARALAMPOUS, KD; KINROSS-WRIGHT, J | 1 |
| DORDEVIC, D; KANDIC, B | 1 |
| KEELER, MH | 1 |
| ADEY, WR | 1 |
| DOLEZAL, V; HAUSNER, M | 1 |
| LINGL, FA; TOLAN, EJ | 1 |
| BARRON, F; BUNNELL, S; JARVIK, ME | 1 |
| CURTIS, DR | 1 |
| BENOIT, JC; STEVENIN, L | 1 |
| GROF, S | 1 |
| RAJOTTE, P | 1 |
| HOLLISTER, LE | 1 |
| Hollister, LE; Overall, JE | 1 |
| PELICIER, Y | 1 |
| LEVINE, J; LUDWIG, AM | 1 |
| MIYOSHI, A | 1 |
| NOMURA, J | 1 |
| BONINO, D; GAMNA, G | 1 |
| Johnsen, G | 1 |
| Alnaes, R | 1 |
| ISBELL, H | 1 |
| Check, E | 1 |
| Cuddy, ML | 1 |
| Halpern, JH; Pope, HG; Sewell, RA | 1 |
| Griffiths, RR; Jesse, R; McCann, U; Richards, WA | 1 |
| Hunt, N; McCambridge, J; Mitcheson, L; Winstock, A | 1 |
| Amorosi, DJ; Rabin, RA; Rice, KC; Winter, JC | 1 |
| Fantegrossi, WE; Katz, EB; Reissig, CJ; Rice, KC; Winter, JC; Yarosh, HL | 1 |
| Hermle, L; Hewer, W; Kovar, KA; Ruchsow, M | 1 |
| Borgwardt, S; Fusar-Poli, P | 1 |
| Stix, G | 1 |
| Geyer, MA; Halberstadt, AL | 1 |
| Gasse, A; Köhler, H; Martin, R; Pfeiffer, H; Schürenkamp, J | 2 |
| Johansen, PØ; Krebs, TS | 1 |
| Borschmann, R; Kaar, S; Winstock, AR | 1 |
| Kupferschmidt, K | 1 |
| Rucker, JJ | 1 |
| Geyer, MA | 1 |
| Flynn, S; Frowde, KD; Jelen, LA; Rucker, JJ; Young, AH | 1 |
| Goodwin, GM | 1 |
| Spiegel, D | 1 |
| Johnson, MW; Nichols, CD; Nichols, DE | 1 |
| Barrett, AB; Carhart-Harris, RL; Muthukumaraswamy, SD; Schartner, MM; Seth, AK | 1 |
| Larsen, JK | 1 |
| Gallinat, J; Hermle, L; Jungaberle, H; Majić, T; Schmidt, TT; Zeuch, A | 1 |
| Bayat, M | 1 |
| Johnson, MI; Whelan, A | 1 |
| Bird, BM; Lafrance, A; Thiessen, MS; Walsh, Z | 1 |
| Aixalà, M; Bouso, JC; Dos Santos, RG; Hallak, JEC | 1 |
| Alcázar-Córcoles, MÁ; Bouso, JC; Dos Santos, RG; Hallak, JEC | 1 |
| Ross, S | 1 |
| Anderson, B; Klein-Schwartz, W; Leonard, JB | 1 |
| Jalal, B | 1 |
| Andreassen, OA; Kvam, TM; Stewart, LH | 1 |
| Garcia-Romeu, A; Richards, WA | 1 |
| De Gregorio, D; Enns, JP; Gobbi, G; Nuñez, NA; Posa, L | 1 |
| Anderson, T; Dinh-Williams, LA; Farb, NAS; Hapke, E; Hui, K; Petranker, R; Rosenbaum, D; Weissman, CR | 1 |
| Kuypers, KPC | 1 |
| Davis, AK; Griffiths, RR; Hurwitz, ES; Jesse, R; Johnson, MW | 1 |
| Davis, AK; Erowid, E; Erowid, F; Garcia-Romeu, A; Griffiths, RR; Johnson, MW | 1 |
| Dolder, PC; Hutten, NRPW; Kuypers, KPC; Mason, NL | 1 |
| Carhart-Harris, R; Muthukumaraswamy, S; Nutt, D; Pallavicini, C; Tagliazucchi, E; Vilas, MG; Villarreal, M; Zamberlan, F | 1 |
| Anderson, T; Christopher, A; Dinh-Williams, LA; Hapke, E; Hui, K; Petranker, R; Rosenbaum, D; Weissman, C | 1 |
| Ardissino, M; John, C; Muttoni, S | 1 |
| Borgwardt, S; Müller, F | 1 |
| Nutt, D | 1 |
| Amada, N; Jungaberle, H; Klein, M; Lea, T; Schecke, H | 1 |
| Andersson, M; Kjellgren, A | 1 |
| Barnett, L; Carhart-Harris, RL; Muthukumaraswamy, SD; Seth, AK | 1 |
| Carpenter, LL; Kalin, NH; McDonald, WM; Nemeroff, CB; Reiff, CM; Richman, EE; Rodriguez, CI; Widge, AS | 1 |
| Anderson, T; Dinh-Williams, LA; Hapke, E; Hui, K; Petranker, R; Rosenbaum, D; Weissman, C | 1 |
| Güngör, C; Meinhardt, MW; Mertens, LJ; Skorodumov, I; Spanagel, R | 1 |
| Abbott, KL; Boothe, DM; Dhanasekaran, M; Flannery, PC; Gill, KS; Pondugula, SR | 1 |
| Patterson, RE; van Elk, M; van Mulukom, V | 1 |
| Carhart-Harris, R; Menon, DK; Roseman, L; Stamatakis, EA; Varley, TF | 1 |
| Anderson, BT; Danforth, AL; Grob, CS | 1 |
| Chen, Z; Deole, G; Goldberg, SB; Ng, CW; Nicholas, CR; Raison, CL; Shechet, B | 1 |
| Aguilar-Valles, A; De Gregorio, D; Gobbi, G; Heifets, BD; Hibicke, M; Mitchell, J; Preller, KH | 1 |
| Courault, P; Demarquay, G; Lancelot, S; Zimmer, L | 1 |
| Healy, CJ | 1 |
| Barrett, FS; Davis, AK; Griffiths, RR; Gukasyan, N; So, S; Swift, TC | 1 |
| de Manincor, M; Galvão-Coelho, NL; Gonzalez, M; Marx, W; Perkins, D; Sarris, J; Sinclair, J | 1 |
| Balaet, M; Buchborn, T; Carhart-Harris, RL; Erritzoe, D; Kaertner, LS; Kettner, H; Roseman, L; Spriggs, MJ; Steinborn, MB; Timmermann, C | 1 |
| Tullis, P | 1 |
| Bates, MLS; Trujillo, KA | 1 |
| Liokaftos, D | 1 |
| Anderson, T; Barratt, MJ; Ferris, JA; Maier, LJ; Petranker, R; Winstock, AR | 1 |
| Hendricks, PS; Sexton, JD; Simonsson, O | 1 |
| Baker, G; Dos Santos, RG; Dursun, S; Hallak, JE | 1 |
| Berk, M; Bonomo, Y; Carter, O; Castle, D; Davey, C; Forbes, D; Galvão-Coelho, NL; Hood, S; Hoyer, D; Liknaitzky, P; Loo, C; Murray, G; O'Donnell, M; Penington, D; Perkins, D; Rossell, S; Sarris, J; Schubert, V; Siskind, D; Williams, M | 1 |
| Thompson, SM | 1 |
| Gründer, G; Jungaberle, H | 1 |
| Cusimano, J; Hosanagar, A; Radhakrishnan, R | 2 |
| Forsyth, A; Lumley, T; Muthukumaraswamy, SD | 1 |
| de la Salle, S; Fogg, C; Jahn, ZW; Michaels, TI; Williams, MT | 1 |
| Cleary, S; Corrigan, K; Haran, M; Kelly, JR; Kelly, Y; Ledden, K; McCandliss, C; McManus, R; O'Keane, V; Rush, G; Trant, R | 1 |
| Waters, K | 1 |
| Leger, RF; Unterwald, EM | 1 |
| Kadeřábek, L; Koudelka, V; Novák, T; Páleníček, T; Piorecká, V; Tylš, F; Vejmola, Č | 1 |
| de Wit, H; Lee, R; Malina, M; Murray, CH; Perry, CM; Tare, I | 1 |
| Barnett, BS; Parker, SE; Weleff, J | 1 |
| Holze, F; Liechti, ME | 1 |
| Paracha, SU; Redden, WM; Sheheryar, Q | 1 |
| Bourzat, F; Harvey, K; Kryskow, P; Kuypers, KPC; Polito, V; Rootman, JM; Santos-Brault, E; Stamets, P; Walsh, Z | 1 |
| DiBerto, JF; Roth, BL; Slocum, ST | 1 |
| Machado, S; Novais, F; Rema, J; Sousa, TR | 1 |
| Day, K; Galvão-Coelho, NL; Perkins, D; Pinzon Rubiano, D; Sarris, J | 1 |
| Barrett, FS; Doss, MK; Gaddis, A; Griffiths, RR; Madden, MB; Mathur, BN; Nebel, MB | 1 |
| Jones, GM; Nock, MK | 1 |
| Bender, D; Hellerstein, DJ | 1 |
| Erdmann, M; Hase, A; Hasler, G; Limbach, V | 1 |
| Grossman, DH; Hendricks, PS | 1 |
| Becker, A; Borgwardt, S; Holze, F; Kraus, E; Ley, L; Liechti, ME; Müller, F; Schmid, Y; Vizeli, P | 1 |
| Cao, D; Chen, Z; Cheng, J; Fan, L; He, L; Li, J; Liu, X; Luo, Z; Qi, J; Tang, L; Wang, H; Wang, S; Yu, J | 1 |
| Aday, J; Neill, JC; Nutt, DJ; Salam, I; Schlag, AK | 1 |
| Beaussant, Y; Garcia, ACM; Maia, LO | 1 |
| Becker, AM; Duthaler, U; Eckert, A; Holze, F; Kolaczynska, KE; Kuehne, SS; Ley, L; Liechti, ME; Müller, F; Roder, MA; Straumann, I; Varghese, N; Vizeli, P | 1 |
| Hasler, G | 1 |
| de la Fuente Revenga, M; Elder, H; González-Maeso, J; Jaster, AM; Marsh, SA; Negus, SS | 1 |
| Enge, S; Evens, R; Mertens, LJ; Walter, M; Wolff, M | 1 |
| McClure-Begley, TD; Roth, BL | 1 |
| Johnson, MW; Strickland, JC | 1 |
| Hillhouse, TM; Magaraggia, I; Porter, JH; Schreiber, R; van den Berg, M | 1 |
| Bouso Saiz, JC; Dos Santos, RG; Hallak, JEC; Rossi, GN | 1 |
| Bernhardt, B; Carhart-Harris, R; Girn, M; Nathan Spreng, R; Roseman, L; Smallwood, J | 1 |
| Dorsen, CG; Mangini, M; Penn, A; Stein, CA; Van Hope, S | 1 |
| Schindler, EAD | 1 |
| Al-Imam, A; Michalak, M; Motyka, MA; Witulska, Z; Younus, M | 1 |
| Artto, VA; De, S; Rusanen, SS; Schindler, EAD; Storvik, M | 1 |
| da Costa, SC; Gold, M; Oesterle, T; Richelson, E; Rummans, TA | 1 |
| Barnett, BS; Carlo, AD; Doblin, R; Ziegler, K | 1 |
| Belouin, SJ; Berger, A; Coe, MA; Coker, AR; Comer, SD; Griffiths, RR; Heal, DJ; Hendricks, PS; Henningfield, JE; Nichols, CD; Sapienza, F; Vocci, FJ; Zia, FZ | 1 |
| Griffiths, RR; Hurwitz, ES; Mitchell, LN; Nayak, S; Sweeney, MM; Swift, TC | 1 |
| Willyard, C | 1 |
| Breeksema, JJ; Kamphuis, J; Kuin, BW; Schoevers, RA; van den Brink, W; Vermetten, E | 1 |
| Kaypak, AC; Raz, A | 1 |
| Andreasen, JT; Kristensen, JL; Odland, AU | 1 |
| Carhart-Harris, RL; Cruzat, J; Deco, G; Kringelbach, ML; Kuceyeski, A; Luppi, AI; Nutt, DJ; Roseman, L; Singleton, SP; Stamatakis, EA | 1 |
| Silberner, J | 1 |
| Cleare, AJ; Ko, K; Kopra, EI; Rucker, JJ | 1 |
| Bláhová, B; Chomynová, P; Kňažek, F; Kočárová, R; Mravčík, V; Plevková, M; Valeš, K | 1 |
| Campbell, I; Dyck, JRB; Narine, KAD; Nutt, DJ; Vamvakopoulou, IA | 1 |
| Hall, WD; Humphreys, K | 1 |
| Castle, D; Downey, LA; Galvão-Coelho, NL; Gattuso, JJ; Hoyer, D; Jacobson, LH; Lawrence, AJ; Nutt, D; Pagni, BA; Perkins, D; Rossell, SL; Ruffell, S; Sarris, J; Timmermann, C | 1 |
| Hartogsohn, I; Petranker, R | 1 |
| Bühler, KM; Calleja-Conde, J; Echeverry-Alzate, V; Giné, E; López-Moreno, JA; Morales-García, JA | 1 |
| Raz, A; Wong, A | 1 |
| Gowrinathan, S; Heinzerling, K; Kelly, DF; Mallari, RJ; Sergi, K; Sharma, A | 1 |
| Atterwill, CK; Gosden, J; Heal, DJ; Smith, SL | 1 |
| Arias, D; Jones, G; Nock, M | 1 |
| Ashworth, J; Heal, DJ; Henningfield, JE; Smith, SL | 1 |
| Kooijman, NI; Kramers, C; Mulleners, WM; Reuser, A; van der Wal, SEI; Vissers, KCP; Willegers, T | 1 |
| Carhart-Harris, RL; Forstmann, M; Gandy, S; Irvine, A; Kettner, HS; Luke, D; Sagioglou, C | 1 |
| Romach, MK; Sellers, EM | 1 |
| Ferris, JA; Kopra, EI; Kuypers, KP; Rucker, JJ; Winstock, AR; Young, AH | 1 |
| Ali, S; Husain, MI; Leon-Carlyle, M; McIntyre, RS; Rosenblat, JD | 1 |
| Agin-Liebes, G; Feduccia, A; Grinsell, N; Paradise, S; Price, CM; Rabin, DM | 1 |
| Baumann, MH; Belouin, SJ; Berger, A; Dworkin, RH; Ghauri, MH; Hendricks, PS; Henningfield, JE; Lanier, RK; Ross, S; Zia, FZ | 1 |
| Arikci, D; Becker, AM; Coviello, F; Dierbach, S; Duthaler, U; Eckert, A; Holze, F; Klaiber, A; Ley, L; Liechti, ME; Luethi, D; Straumann, I; Thomann, J; Varghese, N | 1 |
| Antenucci, L; Biojone, C; Brunello, CA; Cannarozzo, C; Casarotto, PC; Castrén, E; Diniz, CRAF; Elsilä, LV; Enkavi, G; Fred, SM; Girych, M; Goncharuk, SA; Haapaniemi, H; Kankuri, E; Kaurinkoski, K; Korpi, ER; Kot, EF; Kovaleva, V; Kuutti, M; Meshi, E; Mineev, KS; Moliner, R; Nagaeva, E; Öhman, T; Permi, P; Róg, T; Rubiolo, A; Saarma, M; Sakson, S; Seiffert, N; Varjosalo, M; Vattulainen, I; Vilar, M | 1 |
| Keyes, KM; Patrick, ME | 1 |
| O'Grady, C | 1 |
| Hoeh, NR; Jing, X; Menkes, DB | 1 |
| Arnfred, S; Hovmand, OR; Poulsen, ED; Storebø, OJ | 1 |
| Ezeaka, UC; Kim, HJJ; Laprairie, RB | 1 |
| Crunkhorn, S | 1 |
| Holstein, A; Klumpers, LE; Knowles, R; Mantuani, D; Tagen, M; van Heerden, L | 1 |
| Simon, MA | 1 |
| Belin, AC; Fronczek, R; Gaul, C; Jensen, RH; Lund, NLT; Meisingset, T; Petersen, AS; Steinberg, A; Tfelt-Hansen, J; Tronvik, E | 1 |
| Golebiowska, J; Koniewski, M; Malikowska-Racia, N; Popik, P | 1 |
| Wsół, A | 1 |
| Fabregat-Safont, D; Gomez-Gomez, A; Madrid-Gambin, F; Mason, NL; Olesti, E; Pozo, OJ; Ramaekers, JG | 1 |
92 review(s) available for lysergic acid diethylamide and psilocybin
| Article | Year |
|---|---|
Drug-induced handwriting changes: an empirical review.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Ethanol; Female; Handwriting; Humans; Levodopa; Lysergic Acid Diethylamide; Male; Meprobamate; Middle Aged; Motor Activity; Psilocybin | 1975 |
[The problem of mutagenic side effects of psychotropic substances. 2. Narcotics and addictive drugs].
Topics: Dose-Response Relationship, Drug; Ethanol; Female; Humans; Infant, Newborn; Lysergic Acid Diethylamide; Male; Mescaline; Methadone; Morphine; Mutation; Narcotics; Psilocybin; Substance-Related Disorders | 1979 |
Neurological aspects of hallucinogenic drugs.
Topics: Amphetamines; Animals; Brain; Brain Damage, Chronic; Cannabis; Catecholamines; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Haplorhini; Humans; Injections, Intravenous; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Narcolepsy; Psilocybin; Rats; Seizures; Serotonin Antagonists; Substance-Related Disorders | 1975 |
Chronic cerebral effects of alcohol and drug abuse.
Topics: Alcoholism; Amphetamines; Barbiturates; Brain Diseases; Cannabis; Cerebrovascular Disorders; Cocaine; Humans; Hypnotics and Sedatives; Lysergic Acid Diethylamide; Mescaline; Methylphenidate; Narcotics; Phenmetrazine; Psilocybin; Psychological Tests; Psychoses, Alcoholic; Substance-Related Disorders | 1975 |
Hallucinogens.
Topics: Adolescent; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Phencyclidine; Psilocybin; Substance-Related Disorders | 1987 |
[Do hallucinogens cause chromosomal defects and abnormalities?].
Topics: Abnormalities, Drug-Induced; Animals; Ascomycota; Cannabis; Chromosome Aberrations; Chromosome Disorders; Cricetinae; Drosophila; Edible Grain; Female; Haplorhini; Hematopoietic System; Humans; Leukocytes; Lysergic Acid Diethylamide; Macaca; Mice; Mutation; Plants; Psilocybin; Radiation Genetics; Radioactive Fallout; Rats | 1973 |
[Psychopharmaca in modern medicine].
Topics: Amphetamine; Antidepressive Agents; Barbiturates; Butyrophenones; Chlordiazepoxide; Chlorprothixene; Diazepam; Dibenzazepines; Guaifenesin; Hallucinogens; Humans; Hypnotics and Sedatives; Imipramine; Lithium; Lysergic Acid Diethylamide; Methylphenidate; Monoamine Oxidase Inhibitors; Oxazepam; Phenmetrazine; Phenothiazines; Phytotherapy; Piperidines; Plants, Medicinal; Psilocybin; Psychopharmacology; Rauwolfia; Reserpine; Tranquilizing Agents; Xanthenes | 1968 |
Analysis of hallucinogenic drugs.
Topics: Amphetamine; Cannabis; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Dronabinol; Fluorometry; Hallucinogens; Indoles; Lysergic Acid Diethylamide; Mescaline; Methods; Phencyclidine; Psilocybin; Specimen Handling; Spectrophotometry; Tryptamines | 1972 |
Specific pharmacological management of acute toxicity due to "psychedelic" drugs.
Topics: Acute Disease; Alkaloids; Amines; Amphetamine; Antidotes; Atropa belladonna; Cannabis; Ergolines; Hallucinogens; Humans; Indoles; Lysergic Acid Diethylamide; Parasympatholytics; Phencyclidine; Phenethylamines; Plants, Medicinal; Plants, Toxic; Psilocybin; Toxicology | 1972 |
Psychotomimetic drugs: biochemistry and pharmacology.
Topics: Acetylcholine; Alkaloids; Amines; Animals; Brain; Bufotenin; Cannabis; Chemical Phenomena; Chemistry; Dronabinol; Electroencephalography; Hallucinogens; Humans; Indoles; Lysergic Acid Diethylamide; Mescaline; Phenethylamines; Psilocybin; Structure-Activity Relationship; Tryptamines | 1973 |
The pharmacology of hallucinogens.
Topics: Amphetamine; Animals; Cats; Central Nervous System; Cerebral Cortex; Dronabinol; Evoked Potentials; Geniculate Bodies; Guinea Pigs; Hallucinogens; Haplorhini; Humans; Limbic System; Lysergic Acid Diethylamide; Macaca; Mescaline; Phenethylamines; Psilocybin; Rabbits; Rats; Reticular Formation; Retina; Sensory Receptor Cells; Serotonin; Stimulation, Chemical; Structure-Activity Relationship; Thalamic Nuclei; Visual Perception | 1972 |
Psychedelic drugs.
Topics: Adolescent; Adult; Cannabis; Drug and Narcotic Control; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Middle Aged; Psilocybin; Substance-Related Disorders | 1968 |
Psychedelic drugs.
Topics: Adolescent; Adult; Cannabis; Drug and Narcotic Control; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Middle Aged; Psilocybin; Substance-Related Disorders | 1968 |
[LSD and related hallucinogens. History--effect--use and dangers].
Topics: Autonomic Nervous System; Cannabis; Chemistry; Culture; Hallucinogens; History, 20th Century; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychotic Disorders | 1967 |
Hallucinogenic plants. Various chemical substances are known to be the active hallucinogenic principles in many plants.
Topics: Basidiomycota; Benzopyrans; Cannabis; Chemistry, Pharmaceutical; Ergonovine; Eugenol; Hallucinogens; Indoles; Lysergic Acid Diethylamide; Mescaline; Oxazoles; Parasympathomimetics; Phenethylamines; Picolines; Plants, Medicinal; Psilocybin; Pyridines; Seeds; Stereoisomerism; Tryptamines | 1968 |
Psychedelic drugs and mystical experience.
Topics: Cognition; Dextroamphetamine; Esthetics; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mysticism; Psilocybin; Religion; Substance-Related Disorders; Unconscious, Psychology | 1969 |
[The abuse of psychodelics: a social and medical problem].
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Social Problems; Substance-Related Disorders | 1970 |
[Relation of monoamines to mental disorders].
Topics: Amines; Animals; Bipolar Disorder; Catecholamines; Central Nervous System; Depression; Dihydroxyphenylalanine; Dopamine; Epinephrine; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Methylation; Monoamine Oxidase Inhibitors; Phenethylamines; Psilocybin; Reserpine; Schizophrenia; Serotonin; Tryptamines | 1970 |
Effects of drugs on perception in man.
Topics: Afterimage; Amobarbital; Amphetamine; Animals; Antidepressive Agents; Auditory Perception; Barbiturates; Body Image; Chlorpromazine; Color Perception; Dextroamphetamine; Electroencephalography; Flicker Fusion; Hallucinations; Hallucinogens; Humans; Illusions; Lysergic Acid Diethylamide; Mescaline; Methamphetamine; Perception; Perceptual Disorders; Personality; Phenobarbital; Psilocybin; Reserpine; Time Perception; Tranquilizing Agents; Visual Acuity; Visual Perception | 1970 |
[Narcotics abuse in adolescents].
Topics: Adolescent; Age Factors; Cannabis; Conflict, Psychological; Family Characteristics; Forensic Medicine; Germany, West; Hallucinogens; Health Education; Humans; Lysergic Acid Diethylamide; Mescaline; Motivation; Narcotics; Opium; Psilocybin; Psychopharmacology; Substance-Related Disorders | 1971 |
[Tracing of addictive drugs].
Topics: Cannabis; Chromatography, Paper; Chromatography, Thin Layer; Fluorometry; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Methamphetamine; Methods; Morphine; Opium; Psilocybin; Spectrum Analysis; Tryptamines | 1971 |
Drugs alter web-building of spiders: a review and evaluation.
Topics: Animals; Behavior, Animal; Chlorpromazine; Dextroamphetamine; Diazepam; Evaluation Studies as Topic; Female; Light; Lysergic Acid Diethylamide; Motion Pictures; Pentobarbital; Phenobarbital; Photography; Psilocybin; Scopolamine; Spiders; Temperature | 1971 |
Social and medical aspects of illicit use of LSD.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Animals; Commerce; Female; Humans; Jurisprudence; Lysergic Acid Diethylamide; Male; Maternal-Fetal Exchange; Pregnancy; Psilocybin; Religion; Sex Chromosome Aberrations; Social Class; Social Conformity; Social Control, Formal; Students; Substance-Related Disorders; Suicide; Unemployment; United States | 1971 |
Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine.
Topics: Amines; Animals; Brain Chemistry; Bufotenin; Hallucinogens; Indoles; Lysergic Acid Diethylamide; N,N-Dimethyltryptamine; Neurons; Psilocybin; Raphe Nuclei; Rats; Receptors, Neurotransmitter; Reserpine; Serotonin; Synaptic Vesicles | 1982 |
Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.
Topics: Anesthetics, Dissociative; Brain; Consciousness; Dopamine; Glutamic Acid; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Psilocybin; Serotonin | 1998 |
Recreational drug misuse: issues for the cardiologist.
Topics: Adolescent; Adult; Amphetamines; Cannabis; Cardiovascular Diseases; Child; Cocaine; Drug Overdose; Female; Hallucinogens; Heroin; Humans; Lysergic Acid Diethylamide; Male; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Psilocybin; Substance-Related Disorders | 2000 |
[REVIEW OF PSYCHODYSLEPTICS: I. CLASSIFICATION OF PSYCHODYSLEPTICS].
Topics: Adrenochrome; Anesthetics; Bufotenin; Electroencephalography; Epinephrine; Hallucinogens; Indoles; Lysergic Acid Diethylamide; Mescaline; Norepinephrine; Parasympatholytics; Phencyclidine; Piperidines; Psilocybin; Serotonin; Toxicology; Tryptamines | 1964 |
Common drugs of abuse--Part II.
Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States | 2004 |
[Hallucinogen-induced psychological disorders].
Topics: Adolescent; Adult; Hallucinogens; Humans; Lysergic Acid Diethylamide; N,N-Dimethyltryptamine; Psilocybin; Psychoses, Substance-Induced; Recurrence; Substance-Related Disorders | 2008 |
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.
Topics: Animals; Behavior; Behavior, Animal; Hallucinogens; Humans; Lysergic Acid Diethylamide; Nerve Tissue Proteins; Neurons; Phenethylamines; Presynaptic Terminals; Psilocybin; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Serotonin Syndrome; Synaptic Transmission | 2011 |
Psychedelics in the treatment of unipolar mood disorders: a systematic review.
Topics: Depressive Disorder, Treatment-Resistant; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Pilot Projects; Psilocybin; Treatment Outcome | 2016 |
Psychedelics as Medicines: An Emerging New Paradigm.
Topics: Anxiety; Brain; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Hallucinogens; Humans; Inflammation; Inflammation Mediators; Lysergic Acid Diethylamide; Mental Disorders; Mind-Body Therapies; Obsessive-Compulsive Disorder; Psilocybin; Psychotherapy; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Severity of Illness Index; Substance-Related Disorders | 2017 |
[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
Topics: Combined Modality Therapy; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy; Serotonin Agents; Treatment Outcome | 2017 |
[Classic psychedelic drugs and their potential therapeutic effect].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cluster Headache; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT2A; Substance-Related Disorders | 2017 |
Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
Topics: Anxiety; Chronic Pain; Depression; Humans; Lysergic Acid Diethylamide; Pain; Psilocybin; Serotonin Receptor Agonists; Treatment Outcome | 2018 |
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
Topics: Anxiety Disorders; Banisteriopsis; Depressive Disorder; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Randomized Controlled Trials as Topic; Serotonin Agents; Substance-Related Disorders | 2018 |
Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.
Topics: Anxiety; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Serotonin Antagonists; Stress, Psychological | 2018 |
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
Topics: Animals; Dopamine; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neuropharmacology; Piperidines; Psilocybin; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sleep; Sleep Paralysis; Urea | 2018 |
Psychedelic drugs in the treatment of anxiety, depression and addiction.
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Hallucinogens; Humans; Lysergic Acid Diethylamide; Obsessive-Compulsive Disorder; Psilocybin; Substance-Related Disorders | 2018 |
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.
Topics: Biomedical Research; Dose-Response Relationship, Drug; Hallucinogens; History, 20th Century; History, 21st Century; Humans; Lysergic Acid Diethylamide; Psilocybin; Psychotherapy; Serotonin Antagonists | 2018 |
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
Topics: Animals; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin | 2018 |
Cessation and reduction in alcohol consumption and misuse after psychedelic use.
Topics: Adult; Alcohol Drinking; Cross-Sectional Studies; Ethanol; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mysticism; Psilocybin; Psychotropic Drugs; Retrospective Studies; Substance-Related Disorders; Surveys and Questionnaires | 2019 |
Classical psychedelics for the treatment of depression and anxiety: A systematic review.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2019 |
Acute effects of lysergic acid diethylamide (LSD) on resting brain function.
Topics: Brain; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2019 |
Psychedelic drugs-a new era in
psychiatry?
.
Topics: Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychiatry | 2019 |
Psychedelics and Psychedelic-Assisted Psychotherapy.
Topics: Evidence-Based Practice; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy | 2020 |
Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
Topics: Banisteriopsis; Evidence-Based Practice; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Psilocybin; Randomized Controlled Trials as Topic | 2020 |
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.
Topics: Animals; Brain; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Mental Disorders; Mental Health; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Randomized Controlled Trials as Topic | 2021 |
Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives.
Topics: Antibodies, Monoclonal; Botulinum Toxins, Type A; Capsaicin; Carbon Dioxide; Clinical Trials as Topic; Cluster Headache; Humans; Ketamine; Lysergic Acid Diethylamide; Oxazolidinones; Psilocybin; Receptors, Calcitonin Gene-Related Peptide; Somatostatin; Tryptamines | 2021 |
The acute effects of classic psychedelics on memory in humans.
Topics: Banisteriopsis; Dose-Response Relationship, Drug; Hallucinogens; Humans; Lysergic Acid Diethylamide; Memory Disorders; Memory, Episodic; Memory, Short-Term; Mental Recall; Psilocybin; Psychotherapy | 2021 |
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.
Topics: Affect; Banisteriopsis; Depression; Depressive Disorder, Major; Double-Blind Method; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome | 2021 |
Use and abuse of dissociative and psychedelic drugs in adolescence.
Topics: Adolescent; Adult; Age Factors; Animals; Dextromethorphan; Female; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psilocybin; Risk-Taking; Substance-Related Disorders | 2021 |
Optimizing psychedelic compounds for neuropsychiatric therapy.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Psilocybin | 2021 |
Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects.
Topics: Banisteriopsis; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychopharmacology | 2021 |
Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence.
Topics: Banisteriopsis; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin | 2021 |
Blinding and expectancy confounds in psychedelic randomized controlled trials.
Topics: Confounding Factors, Epidemiologic; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Mental Disorders; Psilocybin; Randomized Controlled Trials as Topic; Research Design | 2021 |
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.
Topics: Affect; Anxiety Disorders; Banisteriopsis; Depressive Disorder; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Hallucinogen Use and Misuse in Older Adults.
Topics: Aged; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Molecular insights into psychedelic drug action.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Psilocybin; United States | 2022 |
Psychedelic medicines for mood disorders: current evidence and clinical considerations.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin; Psychotherapy | 2022 |
Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.
Topics: Banisteriopsis; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Risk Assessment | 2022 |
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.
Topics: Communication; Drug Overdose; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.
Topics: Anxiety; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
The promises and perils of psychedelic pharmacology for psychiatry.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Psilocybin; Psychiatry; Receptor, Serotonin, 5-HT2A | 2022 |
Human behavioral pharmacology of psychedelics.
Topics: Alcoholism; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.
Topics: Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Midwifery; Pregnancy; Psilocybin; Psychotherapy | 2022 |
Psychedelics in the Treatment of Headache and Chronic Pain Disorders.
Topics: Chronic Pain; Hallucinogens; Headache; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.
Topics: Cluster Headache; Humans; Lysergic Acid Diethylamide; Psilocybin; Retrospective Studies; Self Report; Surveys and Questionnaires | 2022 |
Psychedelic drugs for psychiatric disorders.
Topics: Alcoholism; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Psilocybin | 2022 |
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.
Topics: Controlled Substances; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders; United States | 2022 |
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.
Topics: Banisteriopsis; Hallucinogens; Headache; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin | 2022 |
Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N,N-Dimethyltryptamine; Psilocybin | 2022 |
Animal Behavior in Psychedelic Research.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Serotonin | 2022 |
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.
Topics: Depression; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2023 |
Mescaline: The forgotten psychedelic.
Topics: Animals; Hallucinogens; Humans; Lysergic Acid Diethylamide; Memory Disorders; Mescaline; Psilocybin; Serotonin 5-HT2 Receptor Agonists | 2023 |
Default Mode Network Modulation by Psychedelics: A Systematic Review.
Topics: Brain; Default Mode Network; Hallucinogens; Lysergic Acid Diethylamide; Magnetic Resonance Imaging; Psilocybin | 2023 |
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.
Topics: Alcoholism; Animals; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 2022 |
Microdosing with classical psychedelics: Research trajectories and practical considerations.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Health; Psilocybin; United States | 2022 |
Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Neurosurgery; Psilocybin; Quality of Life | 2023 |
Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.
Topics: Animals; Brain; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Serotonin; Treatment Outcome | 2023 |
Are psychedelics the answer to chronic pain: A review of current literature.
Topics: Chronic Pain; Cluster Headache; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Randomized Controlled Trials as Topic | 2023 |
Psychedelics: Science sabotaged by Social Media.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Psilocybin; Social Media | 2023 |
The need for establishing best practices and gold standards in psychedelic medicine.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Health; Psilocybin; Stress Disorders, Post-Traumatic | 2023 |
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.
Topics: Chronic Pain; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Quality of Life; United States | 2023 |
Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.
Topics: Death; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Terminal Care | 2023 |
Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.
Topics: Anxiety Disorders; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Randomized Controlled Trials as Topic | 2023 |
Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.
Topics: Anxiety; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Psilocybin; Substance-Related Disorders | 2023 |
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.
Topics: Hallucinogens; Heart Valve Diseases; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Serotonin | 2023 |
Ensuring psychedelic treatments and research do not leave anyone behind.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Psilocybin | 2024 |
Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments-a consensus article.
Topics: Cluster Headache; Consensus; Europe; Humans; Lithium Compounds; Lysergic Acid Diethylamide; Oxygen; Patients; Physicians; Prednisone; Preventive Medicine; Psilocybin; Topiramate; Tryptamines; Verapamil | 2023 |
Cardiovascular safety of psychedelic medicine: current status and future directions.
Topics: Anxiety Disorders; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 2023 |
Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N,N-Dimethyltryptamine; Psilocybin | 2023 |
10 trial(s) available for lysergic acid diethylamide and psilocybin
| Article | Year |
|---|---|
2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
Topics: Adult; Amphetamine; Blood Pressure; Catecholamines; Chlorpromazine; Clinical Trials as Topic; Euphoria; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Perception; Psilocybin; Psychopharmacology; Pupil | 1967 |
[Experimental psychosis after administration of benactyzine].
Topics: Benactyzine; Central Nervous System; Clinical Trials as Topic; Electroencephalography; Hallucinations; Humans; Hydroxyindoleacetic Acid; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Serotonin | 1966 |
Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.
Topics: Clinical Trials as Topic; Drug Tolerance; Humans; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Placebos; Psilocybin | 1965 |
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
Topics: Adult; Affect; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Hallucinogens; Heart Rate; Humans; Lysergic Acid Diethylamide; Male; Psilocybin; Spirituality; Substance-Related Disorders; Surveys and Questionnaires | 2006 |
Decreased directed functional connectivity in the psychedelic state.
Topics: Adult; Anticonvulsants; Cerebral Cortex; Connectome; Female; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Magnetoencephalography; Male; Nerve Net; Psilocybin; Tiagabine; Young Adult | 2020 |
Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy | 2021 |
Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.
Topics: Adolescent; Adult; Affect; Double-Blind Method; Evoked Potentials; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Psilocybin; Young Adult | 2022 |
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; National Institutes of Health (U.S.); Psilocybin; United States | 2022 |
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
Topics: Double-Blind Method; Female; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Male; Psilocybin | 2022 |
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
Topics: Cross-Over Studies; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 2023 |
218 other study(ies) available for lysergic acid diethylamide and psilocybin
| Article | Year |
|---|---|
Hypothesis: migraine, a central biochemical dysnociception.
Topics: Adult; Animals; Apomorphine; Circadian Rhythm; Dopamine; Female; Fever; Headache; Humans; Levodopa; Lysergic Acid Diethylamide; Male; Migraine Disorders; Nervous System; Norepinephrine; Pain; Perceptual Disorders; Phenylalanine; Psilocybin; Rats; Reserpine; Serotonin; Sleep; Somatosensory Cortex; Synaptic Transmission | 1976 |
Color changes induced by certain indole alkaloids in the fiddler crab, Uca.
Topics: Adaptation, Physiological; Animals; Brachyura; Dose-Response Relationship, Drug; Eye; Light; Lysergic Acid Diethylamide; Muscles; Ocular Physiological Phenomena; Psilocybin; Retinal Pigments; Time Factors | 1975 |
A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
Topics: Adolescent; Adult; Amphetamines; Female; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Middle Aged; N,N-Dimethyltryptamine; Psilocybin; Psychoses, Substance-Induced; Schizophrenia | 1977 |
Comparative effects of hallucinogenic drugs on behavior of the cat.
Topics: Animals; Behavior, Animal; Cats; DOM 2,5-Dimethoxy-4-Methylamphetamine; Female; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Psilocybin | 1977 |
LSD.
Topics: Chemistry; History, 20th Century; Illicit Drugs; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 1979 |
Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Catecholamines; Clonidine; Dose-Response Relationship, Drug; Lysergic Acid Diethylamide; Male; Mescaline; Methyltyrosines; Mice; Motor Activity; Phenoxybenzamine; Psilocybin; Receptors, Dopamine; Reserpine | 1977 |
The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.
Topics: Aniline Compounds; Animals; Appetite Depressants; Dextroamphetamine; Dogs; Dose-Response Relationship, Drug; Female; Lysergic Acid Diethylamide; Male; Mescaline; Psilocybin | 1979 |
Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test.
Topics: Animals; Azathioprine; Bone Marrow; Chromosome Aberrations; Dronabinol; Lysergic Acid Diethylamide; Mice; Mutagens; Psilocybin | 1978 |
Treatment of alcoholism with psychotomimetic drugs. A follow-up study.
Topics: Adult; Alcoholism; Follow-Up Studies; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psilocybin; Psychotherapy | 1978 |
Status of drug quality in the street-drug market--an update.
Topics: Amphetamine; Amphetamines; Cannabis; Cocaine; Dronabinol; Heroin; Humans; Lysergic Acid Diethylamide; Mescaline; Opium; Pharmaceutical Preparations; Psilocybin; Substance-Related Disorders | 1976 |
An animal behavior model for studying the actions of LSD and related hallucinogens.
Topics: Animals; Behavior, Animal; Cats; Drug Tolerance; Female; Grooming; Lysergic Acid Diethylamide; Methysergide; Movement; Psilocybin; Serotonin; Time Factors; Vocalization, Animal | 1976 |
Discriminable stimuli produced by hallucinogens.
Topics: Animals; Discrimination, Psychological; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Phencyclidine; Psilocybin; Rats | 1976 |
Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.
Topics: Animals; Bufotenin; Hallucinogens; In Vitro Techniques; Indoles; Lysergic Acid Diethylamide; Male; N,N-Dimethyltryptamine; Psilocybin; Rats; Receptors, Drug; Serotonin; Synapses | 1975 |
Management of hallucinogen abuse.
Topics: Adolescent; Adult; Amphetamines; Basidiomycota; Cannabis; Child; Condiments; Diazepam; Fruit; Hallucinogens; Humans; Hyperkinesis; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Phencyclidine; Plants; Psilocybin; Substance-Related Disorders | 1976 |
Drug-induced conditioned suppression: specificity due to drug employed as UCS.
Topics: Animals; Atropine; Atropine Derivatives; Conditioning, Classical; Lysergic Acid Diethylamide; Male; Pentobarbital; Psilocybin; Rats; Reinforcement Schedule | 1976 |
Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
Topics: Animals; Brain; Cerebral Cortex; Down-Regulation; Ketanserin; Lysergic Acid Diethylamide; Male; Mescaline; Organ Specificity; Psilocybin; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reference Values | 1990 |
Hallucinogenic mushrooms.
Topics: Adolescent; Female; Humans; Lysergic Acid Diethylamide; Male; Mushroom Poisoning; Psilocybin; Substance-Related Disorders | 1988 |
Relief of obsessive-compulsive symptoms by LSD and psilocin.
Topics: Adolescent; Humans; Lysergic Acid Diethylamide; Male; Obsessive-Compulsive Disorder; Psilocybin; Serotonin; Substance-Related Disorders | 1987 |
Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio).
Topics: Animals; Cerebral Cortex; Electroencephalography; Epilepsy; Haplorhini; Light; Lysergic Acid Diethylamide; Mescaline; Methysergide; Papio; Psilocybin; Tryptamines | 1971 |
An analysis of some discriminative properties of d-amphetamine.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Caffeine; Cues; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Mescaline; Methamphetamine; Methyltyrosines; Psilocybin; Rats; Time Factors | 1974 |
[Investigation of psychotropic substances in man].
Topics: Behavior; Carbamazepine; Dose-Response Relationship, Drug; Drug Evaluation; Electroencephalography; Humans; Hypnotics and Sedatives; Imipramine; Lysergic Acid Diethylamide; MMPI; Models, Psychological; Personality; Placebos; Psilocybin; Psychotropic Drugs | 1974 |
[Electrophysiological effects of psilocybin in a cercopithecinae, Papio papio].
Topics: Animals; Cerebral Cortex; Electroencephalography; Electroretinography; Evoked Potentials; Female; Geniculate Bodies; Haplorhini; Light; Lysergic Acid Diethylamide; Noise; Psilocybin; Retina; Vision, Ocular; Visual Cortex | 1969 |
5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine.
Topics: Brain Chemistry; Drug Hypersensitivity; Fenclonine; Headache; Humans; Lysergic Acid Diethylamide; Metaraminol; Migraine Disorders; Norepinephrine; Psilocybin; Serotonin; Syndrome | 1973 |
The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats.
Topics: Alkaloids; Amphetamine; Animals; Body Temperature; Drug Interactions; Fenclonine; Indoles; Lysergic Acid Diethylamide; Male; Psilocybin; Pyridines; Rats; Rats, Inbred Strains; Time Factors; Yeast, Dried | 1973 |
The action of some neuro- and psychopharmacological agents on the membrane ATP-ase of cortical synaptosomes.
Topics: Adenosine Triphosphatases; Amphetamine; Animals; Cerebral Cortex; Chlorpromazine; Dose-Response Relationship, Drug; Guinea Pigs; Haloperidol; In Vitro Techniques; Lysergic Acid Diethylamide; Membranes; Morphine; Ouabain; Phenobarbital; Psilocybin; Synaptosomes | 1971 |
A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
Topics: Animals; Behavior, Animal; Chlorpromazine; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dronabinol; Fenclonine; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Rats; Scopolamine | 1973 |
Effect of acute axotomy (spinal cord transection) on the turnover of 5-hydroxytryptamine.
Topics: Acetamides; Amphetamine; Animals; Catechols; Fenclonine; Hallucinogens; Hydroxyindoleacetic Acid; Lysergic Acid Diethylamide; Monoamine Oxidase Inhibitors; N,N-Dimethyltryptamine; Nerve Degeneration; Nerve Endings; Neural Conduction; Neurons; Nialamide; Psilocybin; Rats; Reserpine; Serotonin; Spinal Cord; Time Factors; Tryptophan Hydroxylase | 1974 |
The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits.
Topics: Alkaloids; Amphetamine; Animals; Body Temperature; Drug Synergism; Female; Fenclonine; Indoles; Lysergic Acid Diethylamide; Psilocybin; Pyridines; Rabbits; Stimulation, Chemical; Time Factors | 1974 |
Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.
Topics: Acetylcholine; Angiotensin II; Animals; Atropine; Bradykinin; Dose-Response Relationship, Drug; Epinephrine; Female; Hallucinogens; Humans; In Vitro Techniques; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Serotonin; Sheep; Sympatholytics; Tripelennamine; Umbilical Arteries; Umbilical Cord; Umbilical Veins; Vasoconstrictor Agents | 1973 |
The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ.
Topics: Action Potentials; Animals; Cats; Electric Stimulation; Ganglia, Autonomic; Hallucinogens; Lysergic Acid Diethylamide; Methysergide; N,N-Dimethyltryptamine; Psilocybin; Serotonin; Synaptic Transmission; Tachyphylaxis; Tryptamines | 1974 |
The psychology of hallucinogenic drug discontinuers.
Topics: Adult; Anxiety; Depression; Female; Gambling; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Mescaline; MMPI; Personality; Psilocybin; Psychological Tests; Substance-Related Disorders | 1972 |
Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.
Topics: Adult; Blood-Brain Barrier; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Emotions; Female; Hallucinations; Headache; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psilocybin; Receptors, Drug; Serotonin; Structure-Activity Relationship | 1974 |
Contractile responses of guinea pig umbilical arteries to various hallucinogenic agents.
Topics: Anilides; Animals; Bromine; Cinnamates; Dose-Response Relationship, Drug; Female; Fetus; Guinea Pigs; Hallucinogens; In Vitro Techniques; Lysergic Acid Diethylamide; Mescaline; Muscle Contraction; Muscle, Smooth; Pregnancy; Psilocybin; Stimulation, Chemical; Sulfides; Umbilical Arteries | 1974 |
Analytical study of some important hallucinogens by a combined fluorimetric and phosphorimetric method.
Topics: Chromatography, Thin Layer; Crystallography; Evaluation Studies as Topic; Hallucinogens; Hydrogen-Ion Concentration; Luminescent Measurements; Lysergic Acid Diethylamide; Mescaline; Methods; N,N-Dimethyltryptamine; Psilocybin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Temperature; Time Factors | 1973 |
Molecular orbital studies on the conformation of hallucinogenic indolealkylamines and related compounds. The isolated molecules and the solvent effect.
Topics: Amines; Chemical Phenomena; Chemistry; Crystallography; Hallucinogens; Indoles; Lysergic Acid Diethylamide; Molecular Conformation; N,N-Dimethyltryptamine; Psilocybin; Quantum Theory; Serotonin; Solvents; Tryptamines; Yohimbine | 1974 |
[Halluciogenic substances and sleep mechanisms].
Topics: 5-Hydroxytryptophan; Animals; Atropine; Behavior, Animal; Cats; Cerebral Cortex; Drug Combinations; Electroencephalography; Electromyography; Electrooculography; Glycolates; Hallucinogens; Hippocampus; Lysergic Acid Diethylamide; Mescaline; Piperidines; Psilocybin; Pyrrolidines; Sleep | 1972 |
A rapid screening procedure for some "street drugs" by thin-layer chromatography.
Topics: Aldehydes; Amphetamine; Chromatography, Thin Layer; Hallucinogens; Humans; Indicators and Reagents; Lysergic Acid Diethylamide; Mescaline; Methods; p-Dimethylaminoazobenzene; Phencyclidine; Platinum; Psilocybin; Solvents; Strychnine; Substance-Related Disorders | 1972 |
[Various psychodysleptic substances].
Topics: Animals; Brain; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 1972 |
Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.
Topics: Amphetamine; Crystallography; Hallucinogens; Lysergic Acid Diethylamide; Molecular Conformation; Psilocybin; Tryptamines; X-Ray Diffraction | 1973 |
[Electroencephalography in drug addicts].
Topics: Cannabis; Electroencephalography; Humans; Lysergic Acid Diethylamide; Mescaline; Morphine Dependence; Psilocybin; Substance-Related Disorders | 1973 |
Some U.S. street drug identification programs.
Topics: Amphetamine; Barbiturates; Cannabis; Chemistry, Pharmaceutical; Cocaine; Community Pharmacy Services; Dronabinol; Drug and Narcotic Control; Humans; Lysergic Acid Diethylamide; Mescaline; Opium; Pharmacognosy; Psilocybin; United States | 1973 |
Recent trends in nonmedical use of drugs reported by students in two suburban New Jersey communities.
Topics: Adolescent; Age Factors; Cannabis; Cocaine; Female; Follow-Up Studies; Heroin Dependence; Humans; Hypnotics and Sedatives; Lysergic Acid Diethylamide; Male; Mescaline; Methamphetamine; New Jersey; Nonprescription Drugs; Peer Group; Psilocybin; Sex Factors; Smoking; Students; Substance-Related Disorders; Surveys and Questionnaires | 1973 |
Theoretical studies on the conformations of psilocin and mescaline.
Topics: Chemical Phenomena; Chemistry; Lysergic Acid Diethylamide; Mescaline; Molecular Conformation; Psilocybin | 1973 |
A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
Topics: Animals; Brain; Catecholamines; Cold Temperature; Dextroamphetamine; Dopamine; Hallucinogens; Lysergic Acid Diethylamide; Male; Mescaline; Norepinephrine; Normetanephrine; Psilocybin; Rats; Stress, Physiological; Swimming; Time Factors; Tritium; Tyrosine; Water | 1974 |
[Observations on naive behavior].
Topics: Animals; Behavior; Behavior, Animal; Hallucinogens; Haplorhini; Humans; Lysergic Acid Diethylamide; Psilocybin | 1967 |
Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio).
Topics: Animals; Ergolines; Evoked Potentials; Eye Movements; Haplorhini; Light; Lysergic Acid Diethylamide; Methylergonovine; Methysergide; Motor Activity; Muscle Tonus; Myoclonus; Psilocybin; Seizures; Tryptamines | 1970 |
Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
Topics: Amphetamine; Animals; Discrimination Learning; Female; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Rats | 1972 |
A perspective on drug abuse.
Topics: Affective Symptoms; Alcoholic Beverages; Amphetamine; Barbiturates; Cannabis; Drug and Narcotic Control; Heroin; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Substance-Related Disorders; Tranquilizing Agents; United States | 1971 |
[Pharmacological action spectra of hallucinogens].
Topics: Amphetamine; Animals; Atropine; Autonomic Nervous System; Brain; Dronabinol; Hallucinogens; Learning; Lysergic Acid Diethylamide; Mental Processes; Mescaline; Psilocybin; Rats; Scopolamine | 1971 |
Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some anti-depressants and hallucinogens.
Topics: Amphetamine; Animals; Antidepressive Agents; Brain; Dibenzazepines; Drug Combinations; Hallucinogens; Hindlimb; Histocytochemistry; Kinetics; Lysergic Acid Diethylamide; Male; Microscopy, Fluorescence; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Psilocybin; Rats; Rats, Inbred Strains; Reflex; Serotonin; Spinal Cord; Temperature; Tryptamines | 1971 |
Effects of excitatory and tranquilizing drugs on visual perception.
Topics: Adult; Female; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Psilocybin; Space Perception; Visual Perception | 1968 |
Further observations regarding hallucinogenic treatment.
Topics: Adult; Erectile Dysfunction; Female; Humans; Lysergic Acid Diethylamide; Male; Neurotic Disorders; Psilocybin; Psychotherapy | 1968 |
Abuse of psychotomimetics.
Topics: Adolescent; Adult; Cannabis; Crime; Denmark; Educational Status; Family; Family Characteristics; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Occupations; Psilocybin; Sex Factors; Social Class; Social Problems; Substance-Related Disorders | 1968 |
Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
Topics: Amines; Animals; Antigen-Antibody Reactions; Binding Sites; Cross Reactions; Ergolines; Ergonovine; Ergot Alkaloids; Ergotamine; Guinea Pigs; Haptens; Hemocyanins; Immune Sera; Iodine Isotopes; Lysergic Acid Diethylamide; Lysine; Melatonin; Mescaline; Phenethylamines; Polymers; Psilocybin; Rabbits; Radioimmunoassay; Receptors, Drug; Serotonin; Sympatholytics; Sympathomimetics; Tryptamines; Tyramine | 1971 |
The uses and abuses of L.S.D. and other hallucinogenic drugs.
Topics: Animals; Chromosomes; Cognition Disorders; Cricetinae; Ethics, Medical; Fear; Female; Hallucinogens; Humans; Lymphocytes; Lysergic Acid Diethylamide; Mice; Psilocybin; Psychotherapy; Rabbits; Rats | 1970 |
The current status of the hallucinogenic drugs.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders | 1970 |
The influence of hallucinogenic drugs upon in vivo brain levels of adenine nucleotides, phosphocreatine and inorganic phosphate in the rat.
Topics: 5-Hydroxytryptophan; Adenine Nucleotides; Animals; Atropine; Brain Chemistry; Cocaine; Dihydroxyphenylalanine; Hallucinogens; Lysergic Acid Diethylamide; Male; Mescaline; Phosphates; Phosphocreatine; Psilocybin; Rats; Scopolamine | 1965 |
A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Behavior, Animal; Ergonovine; Hallucinations; Hallucinogens; Head; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Methysergide; Mice; Phencyclidine; Phenethylamines; Psilocybin; Psychopharmacology; Scopolamine; Tic Disorders; Tryptamines; Yohimbine | 1967 |
The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
Topics: 5-Hydroxytryptophan; Animals; Chlorpromazine; Cyproheptadine; Dogs; Electric Stimulation; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Methamphetamine; Methysergide; Psilocybin; Pulse; Pupil; Reflex, Stretch; Respiration; Serotonin; Spinal Cord; Stimulation, Chemical; Toes; Tryptamines | 1970 |
Stimulation of(14C)serotonin synthesis from (14C)tryptophan by mescaline in rat pineal organ cultures.
Topics: 5-Hydroxytryptophan; Animals; Carbon Isotopes; Deamination; Female; Hydroxyindoleacetic Acid; Lysergic Acid Diethylamide; Melatonin; Mescaline; Organ Culture Techniques; Pineal Gland; Protein Biosynthesis; Proteins; Psilocybin; Rats; Serotonin; Tryptophan | 1971 |
Microbial production of lysergic acid and psyilocybin.
Topics: Ascomycota; Carbon Isotopes; Lysergic Acid Diethylamide; Psilocybin | 1969 |
[Habit forming drugs. 2. Hallucinogens].
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Substance-Related Disorders; Suicide | 1969 |
[Electrographic and behavioral effects of various hallucinogens in the free cat].
Topics: Animals; Behavior, Animal; Cats; Cerebral Cortex; Chemical Phenomena; Chemistry; Electroencephalography; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Motor Activity; Psilocybin; Serotonin; Sleep; Wakefulness | 1969 |
Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
Topics: Animals; Behavior, Animal; Blood Pressure; Blood Pressure Determination; Cats; Conditioning, Classical; Drug Tolerance; Electrodes; Electroencephalography; Electroshock; Escape Reaction; Guinea Pigs; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Methamphetamine; Mixed Function Oxygenases; Muscle Contraction; Nictitating Membrane; Phenylalanine; Psilocybin; Species Specificity; Tryptamines | 1970 |
Deceptions in the illicit drug market.
Topics: Benzopyrans; Cannabis; Chemistry, Pharmaceutical; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Substance-Related Disorders; Tablets; United States | 1970 |
The psycholytic treatment of a childhood schizophrenic girl.
Topics: Child; Female; Humans; Lysergic Acid Diethylamide; Psilocybin; Psychotherapy; Schizophrenia, Childhood | 1970 |
Relative activity of psychotoxic drugs on the avian optic lobe.
Topics: Amphetamine; Animals; Chickens; Electrophysiology; Female; Hallucinations; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Models, Biological; Psilocybin; Tectum Mesencephali | 1970 |
[Investigations of behavior and experimental psychoses].
Topics: Catatonia; Female; Hallucinogens; Humans; Impulsive Behavior; Lysergic Acid Diethylamide; Male; Mescaline; Models, Psychological; Psilocybin; Psychoses, Substance-Induced | 1971 |
[Mood, behavior and drugs].
Topics: Behavior; Brain; Central Nervous System; Drug Hypersensitivity; Emotions; Hallucinogens; Humans; Hypothalamus; Limbic System; Lysergic Acid Diethylamide; Psilocybin; Psychopharmacology | 1971 |
[Hallucinogenic substances].
Topics: Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 1967 |
[Hallucinogens logally classified as narcotics].
Topics: Drug and Narcotic Control; Fentanyl; Germany, West; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 1967 |
The hallucinogenic drugs--their use and abuse.
Topics: Australia; Hallucinogens; Humans; Lysergic Acid Diethylamide; New Zealand; Psilocybin; Substance-Related Disorders | 1968 |
Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines.
Topics: Animals; Body Temperature; Cats; Guinea Pigs; Hallucinogens; Lysergic Acid Diethylamide; Mice; Monoamine Oxidase Inhibitors; Psilocybin; Rabbits; Reflex; Reserpine; Serotonin; Serotonin Antagonists; Tryptamines | 1968 |
[Psychotomimetic effects of the Mexican drug "Ololiuqui"].
Topics: Consciousness; Hallucinogens; Humans; Lysergic Acid Diethylamide; Motor Activity; Psilocybin; Psychometrics; Psychopharmacology; Psychoses, Substance-Induced | 1968 |
Tolerance and cross-tolerance among psychotomimetic drugs.
Topics: Amphetamine; Animals; Behavior, Animal; Drug Tolerance; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Mescaline; Milk; Psilocybin; Rats; Reinforcement, Psychology | 1968 |
Behavioural effects of some morphine antagonists and hallucinogens in the rat.
Topics: Amphetamine; Analgesics; Anesthetics; Animals; Ataxia; Atropine; Azocines; Behavior, Animal; Cyclazocine; Levallorphan; Lysergic Acid Diethylamide; Male; Mescaline; Morphine; Motor Activity; Movement Disorders; Nalorphine; Narcotic Antagonists; Pentazocine; Phencyclidine; Piperidines; Psilocybin; Psychopharmacology; Rats | 1968 |
Prelminary report on the experience with psychosomimetic drugs in the treatment of alcobolism.
Topics: Adult; Alcoholism; Humans; Injections, Intramuscular; Lysergic Acid Diethylamide; Male; Middle Aged; Occupational Therapy; Psilocybin; Psychotherapy | 1968 |
[Is the use of LSD-25 in experimental psychiatry and psychotherapy today still justifiable?].
Topics: Chemical Phenomena; Chemistry; Humans; Lysergic Acid Diethylamide; Mental Disorders; Psilocybin; Psychopharmacology; Psychotherapy | 1968 |
[Pharmacologic properties of partially purified glutamic acid decarboxylase (L-glutamate-1-carboxylyase, E.C. 4.1.1.15) from calf cerebral cortex].
Topics: Animals; Antidepressive Agents; Barbiturates; Carboxy-Lyases; Cattle; Cerebral Cortex; Chemical Phenomena; Chemistry; Chlorpromazine; Codeine; Glutamates; Hydantoins; Imipramine; Lysergic Acid Diethylamide; Phenethylamines; Phenytoin; Primidone; Psilocybin; Pyrrolidines; Spectrophotometry | 1968 |
Some aspects of the current drug scene with emphasis on drugs in use by adolescents.
Topics: Adolescent; Amphetamine; Aphrodisiacs; Cannabis; Condiments; Hallucinogens; Health Education; Heroin; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Substance-Related Disorders; United States | 1968 |
[Toxic ecstasy].
Topics: Basidiomycota; Cannabis; Culture; Ethanol; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Mexico; Nicotiana; Ointments; Plants, Medicinal; Plants, Toxic; Psilocybin; Psychopathology; South America | 1968 |
A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs.
Topics: Animals; Avoidance Learning; Behavior, Animal; Brain Chemistry; Conditioning, Psychological; Hallucinogens; Hypothalamus; Lysergic Acid Diethylamide; Norepinephrine; Psilocybin; Rats; Stimulation, Chemical | 1969 |
Out on a (phantom) limb. Variations on the theme: stability of body image and the golden section.
Topics: Adaptation, Psychological; Amputation, Surgical; Analgesics; Body Image; Female; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Pain; Perceptual Distortion; Phantom Limb; Psilocybin; Space Perception; Time Perception; Visual Perception | 1969 |
[Inhibition of development by psychotics].
Topics: Abnormalities, Drug-Induced; Anesthetics; Animals; Anura; Chick Embryo; Depression, Chemical; Embryo, Nonmammalian; Female; Lysergic Acid Diethylamide; Mescaline; Models, Biological; Phencyclidine; Piperidines; Pregnancy; Pregnancy, Animal; Psilocybin | 1969 |
The effects of psychotomimetic drugs on primary suggestibility.
Topics: Humans; Hypnosis; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Suggestion | 1965 |
[Hullucinogens (psychomimetic substances)].
Topics: Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 1966 |
Inhibition of isolation-induced attack behavior of mice by drugs.
Topics: Animals; Behavior, Animal; Hallucinogens; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Mescaline; Mice; Psilocybin; Social Isolation | 1966 |
Is it possible to induce ESP with psilocybine? An exploratory investigation.
Topics: Adult; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Parapsychology; Psilocybin; Psychological Tests; Telepathy | 1966 |
[Psycho-dysleptics].
Topics: Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 1966 |
Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements.
Topics: Adult; Alcohols; Electrooculography; Eye Movements; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Psilocybin | 1966 |
Inhibition of isolation-induced attack behavior of mice by drugs.
Topics: Aggression; Animals; Behavior, Animal; Environment; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Mice; Psilocybin; Social Isolation | 1966 |
[Neuropharmacologic similarities and differences between the hallucinogens and the antidepressants].
Topics: Animals; Antidepressive Agents; Electrocardiography; Electroencephalography; Electromyography; Hallucinogens; Imipramine; Lysergic Acid Diethylamide; Phencyclidine; Psilocybin; Rabbits; Serotonin | 1966 |
Hallucinogens and dominance behavior of the rat.
Topics: Animals; Behavior, Animal; Lysergic Acid Diethylamide; Mescaline; Mice; Psilocybin; Social Dominance | 1967 |
Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
Topics: Animals; Brain; Chromatography, Gel; Chromatography, Thin Layer; Hallucinogens; Lysergic Acid Diethylamide; Mitochondria; Nerve Endings; Psilocybin; Rats; Receptors, Drug; Reserpine; Serotonin | 1967 |
Dependence on LSD and other hallucinogenic drugs.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Substance-Related Disorders; United States; United States Food and Drug Administration | 1967 |
The hallucinogens and the inhalants.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dronabinol; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Phencyclidine; Psilocybin; Solvents; Substance-Related Disorders | 1984 |
EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
Topics: Animals; Benzopyrans; Cannabinoids; Cats; Dronabinol; Electroencephalography; Female; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Sleep; Wakefulness | 1980 |
LDS-25 as a discriminative stimulus for response selection by pigeons.
Topics: Animals; Columbidae; Discrimination Learning; Lysergic Acid Diethylamide; Male; Mescaline; Metergoline; Psilocybin | 1980 |
Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
Topics: Amphetamines; Animals; Behavior, Animal; Brain Stem; Cats; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electric Conductivity; Female; Kinetics; Lysergic Acid Diethylamide; Mescaline; Neurons; Psilocybin; Raphe Nuclei | 1981 |
Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Hallucinogens; Lysergic Acid Diethylamide; Male; Mescaline; Models, Psychological; Psilocybin; Rats; Rats, Inbred Strains | 1982 |
Drug-induced psychosis: emergency diagnosis and management.
Topics: Amphetamine; Emergency Medical Services; Hallucinogens; Humans; Lysergic Acid Diethylamide; Parasympatholytics; Phencyclidine; Physostigmine; Psilocybin; Psychoses, Substance-Induced; Sympathomimetics | 1981 |
Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.
Topics: Animals; Drug Synergism; Facial Nerve; Hallucinogens; In Vitro Techniques; Injections, Intravenous; Lysergic Acid Diethylamide; Male; Mescaline; Motor Neurons; Norepinephrine; Psilocybin; Rats; Serotonin | 1980 |
[Effect of psilocybin on the behavior of normal mice & waltzing mice; comparison with lysergic acid monoethylamide & diethylamide].
Topics: Animals; Behavior; Hallucinations; Indoles; Lysergic Acid Diethylamide; Mice; Psilocybin | 1959 |
Cross tolerance between LSD and psilocybin.
Topics: Hallucinogens; Indoles; Lysergic Acid Diethylamide; Psilocybin | 1961 |
Controlled sensory input: a note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25.
Topics: Anesthetics; Drug Evaluation; Humans; Indoles; Lysergic Acid Diethylamide; Phencyclidine; Psilocybin; Psychopharmacology | 1960 |
Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.
Topics: Animals; Cats; Electroencephalography; Hallucinogens; Humans; Learning; Lysergic Acid Diethylamide; Psilocybin; Temporal Lobe | 1962 |
[Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
Topics: Hallucinogens; Humans; Indoles; Lysergic Acid Diethylamide; Psilocybin | 1961 |
Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.
Topics: Color Perception; Humans; Lysergic Acid Diethylamide; Mercury; Mescaline; Psilocybin; Syndrome | 1962 |
Mescaline, LSD, psilocybin, and personality change.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Personality; Personality Disorders; Psilocybin | 1963 |
Comparison of psilocin with psilocybin, mescaline and LSD-25.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Mercury; Mescaline; Psilocybin | 1962 |
[The psychomimetic effects of LSD and psilocybin in the clinical exploration of the personality].
Topics: Hallucinations; Humans; Indoles; Lysergic Acid Diethylamide; Personality; Personality Disorders; Physical Examination; Psilocybin | 1963 |
[Auto-experimentation with LSD-25 and psilocybin].
Topics: Empirical Research; Hallucinations; Humans; Indoles; Lysergic Acid Diethylamide; Psilocybin; Research Design | 1963 |
EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.
Topics: Color Perception; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Psilocybin | 1963 |
LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.
Topics: Animals; Behavior, Animal; Fishes; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Research | 1963 |
HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Research; Toxicology | 1963 |
[COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders | 1963 |
THE USE OF HALLUCINOGENIC, PSYCHOTOMIMETIC, PSYCHEDELIC DRUGS IN NORTH CAROLINA.
Topics: Drug Prescriptions; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; North Carolina; Psilocybin; Toxicology | 1963 |
[THE ELABORATION AND STORAGE OF INFORMATION IN THE NERVOUS SYSTEM. A MODEL SUGGESTED BY THE STUDY OF HIPPOCAMPAL MECHANISMS DURING LEARNING].
Topics: Brain; Cats; Diencephalon; Discrimination Learning; Electrophysiology; Hallucinogens; Hippocampus; Indoles; Learning; Lysergic Acid Diethylamide; Psilocybin; Research | 1964 |
[PRACTICAL EXPERIENCES WITH HALLUCINOGENS IN PSYCHOTHERAPY].
Topics: Hallucinogens; Lysergic Acid Diethylamide; Psilocybin; Psychotherapy; Psychotherapy, Group | 1963 |
"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.
Topics: Adolescent; Gasoline; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Petroleum; Projective Techniques; Psilocybin; Psychophysiology; Psychoses, Substance-Induced; Psychotic Disorders; Toxicology | 1964 |
THE HALLUCINOGENIC DRUGS.
Topics: Epinephrine; Ergot Alkaloids; Hallucinogens; Indians, North American; Indoles; Lysergic Acid Diethylamide; Mescaline; Norepinephrine; Pharmacology; Psilocybin; Religion; Serotonin; United States | 1964 |
CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.
Topics: Biomedical Research; Blood; Blood Glucose; Calcium; Chlorides; Creatine; Creatinine; Emotions; Fatty Acids; Glycerides; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Phosphorus; Psilocybin; Psychological Tests; Psychopharmacology; Syndrome; Urine | 1964 |
[FUNDAMENTALS OF A CONDITIONAL-GENETIC PSYCHOPATHOLOGY AS EXEMPLIFIED BY EXPERIMENTAL PSYCHOSIS].
Topics: Hallucinogens; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Neurotic Disorders; Psilocybin; Psychopathology; Psychotherapy; Psychotic Disorders; Toxicology | 1963 |
PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
Topics: Acetylcholine; Cats; Ergonovine; Ergot Alkaloids; Hallucinogens; Indoles; Lysergic Acid Diethylamide; Mescaline; Neural Conduction; Neurons; Neuropharmacology; Oxytocics; Pharmacology; Psilocybin; Research; Sensory Receptor Cells; Serotonin | 1963 |
[USE OF PSYCHOTROPIC DRUGS IN PSYCHOTHERAPY].
Topics: Amobarbital; Amphetamine; Amphetamines; Barbiturates; Hallucinogens; Hexobarbital; Humans; Lysergic Acid Diethylamide; Mescaline; Narcotherapy; Psilocybin; Psychopharmacology; Psychotherapy; Psychotropic Drugs; Thiopental | 1964 |
[APROPOS OF OPTIC DISORDERS IN AUTOEXPERIMENTS WITH HALLUCINOGENS].
Topics: Eye Diseases; Eye Manifestations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Rorschach Test; Visual Perception | 1964 |
EFFECT OF CENTRALLY-ACTING DRUGS ON MOBILIZATION OF FREE FATTY ACIDS.
Topics: Central Nervous System Agents; Chlorpromazine; Desipramine; Fatty Acids; Fatty Acids, Nonesterified; Hallucinogens; Imipramine; Indoles; Lipid Metabolism; Lipids; Lysergic Acid Diethylamide; Mescaline; Pharmacology; Psilocybin; Reserpine; Thioridazine; Tranquilizing Agents | 1964 |
SOURCES OF VARIATION IN REPEATED MEASUREMENT OF PLASMA FREE FATTY ACIDS IN RESTED FASTING SUBJECTS.
Topics: Desipramine; Dietary Fats; Epinephrine; Fasting; Fatty Acids; Fatty Acids, Nonesterified; Imipramine; Lipids; Lysergic Acid Diethylamide; Mescaline; Pharmacology; Psilocybin; Reserpine; Tranquilizing Agents | 1964 |
[SEROTONIN AND PSYCHIATRY].
Topics: Bipolar Disorder; Catecholamines; Drug Therapy; Hallucinations; Hallucinogens; Humans; Hydroxyindoleacetic Acid; Hypoglycemic Agents; Indoleacetic Acids; Lysergic Acid Diethylamide; Mescaline; Metabolism; Monoamine Oxidase Inhibitors; Phenothiazines; Psilocybin; Psychiatry; Psychotic Disorders; Research; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin | 1964 |
PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
Topics: Amphetamine; Amphetamines; Barbiturates; Cannabis; Drug and Narcotic Control; Hallucinogens; Humans; Indoles; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Psychotic Disorders; Sexual Behavior; Substance-Related Disorders; Toxicology | 1965 |
[A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].
Topics: Hallucinogens; Indoles; Lysergic Acid Diethylamide; Psilocybin; Psychopathology; Psychopharmacology; Psychotic Disorders; Research; Toxicology | 1964 |
EFFECTS OF STRESS AND PSYCHOTROPIC DRUGS ON RAT LIVER TRYPTOPHAN PYRROLASE.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Arginine Vasopressin; Chlorpromazine; Cold Temperature; Cortisone; Diazepam; Estradiol; Hypophysectomy; Imipramine; Insulin; Liver; Lysergic Acid Diethylamide; Oxygenases; Oxytocin; Psilocybin; Psychotropic Drugs; Rats; Research; Reserpine; Stress, Physiological; Testosterone; Tetrabenazine; Thyroid Hormones; Tryptophan Oxygenase; Vasopressins | 1965 |
[STUDY OF MODIFICATIONS OF STEREOMORPHISMS OF A SCHIZOPHRENIC PATIENT BY MEANS OF PSYCHOPHARMACOLOGIC DRUGS].
Topics: Antidepressive Agents; Art; Hallucinogens; Humans; Lysergic Acid Diethylamide; Perphenazine; Psilocybin; Psychopharmacology; Research; Schizophrenia | 1964 |
THREE YEARS' EXPERIENCE WITH THE USE OF LSD AS AN AID IN PSYCHOTHERAPY.
Topics: Drug Therapy; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Neurotic Disorders; Prognosis; Psilocybin; Psychoanalytic Therapy; Psychotherapy; Psychotic Disorders | 1964 |
THERAPEUTIC APPLICATION OF THE CHANGE IN CONSCIOUSNESS PRODUCED BY PSYCHOLYTICA (LSD, PSILOCYBIN, ETC.). THE PSYCHEDELIC EXPERIENCE IN THE TREATEMENT OF NEUROSIS.
Topics: Consciousness; Drug Therapy; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neurotic Disorders; Psilocybin; Psychoanalytic Therapy; Psychotherapy; Self Concept | 1964 |
Comparison of the reactions induced by psilocybin and LSD-25 in man.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Psilocybin | 1959 |
Psychedelic drugs: the ups and downs of ecstasy.
Topics: Agaricales; Animals; Anxiety; Brain; Cactaceae; Controlled Clinical Trials as Topic; Female; Hallucinogens; History, 20th Century; History, 21st Century; Humans; Lysergic Acid Diethylamide; Medicine, Traditional; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Phytotherapy; Pilot Projects; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic | 2004 |
Response of cluster headache to psilocybin and LSD.
Topics: Adult; Cluster Headache; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psilocybin; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
Topics: Adult; Cross-Sectional Studies; Female; Hallucinogens; Humans; Incidence; Ketamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Psilocybin; Substance-Related Disorders; United Kingdom | 2007 |
Psilocybin-induced stimulus control in the rat.
Topics: Animals; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Hallucinogens; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psilocybin; Rats; Rats, Inbred F344; Reinforcement Schedule | 2007 |
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
Topics: Animals; Data Interpretation, Statistical; Discrimination Learning; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Piperidines; Psilocybin; Pyridines; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Tryptamines | 2008 |
Albert Hofmann, the father of LSD (1906-2008).
Topics: Hallucinogens; History, 20th Century; History, 21st Century; Humans; Lysergic Acid Diethylamide; Perceptual Disorders; Psilocybin; Switzerland | 2008 |
Return of a problem child.
Topics: Anxiety; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin | 2009 |
[Prof. Günther Hole on his self-experiments. "What did I actually endure?"].
Topics: Electroencephalography; Hallucinogens; Human Experimentation; Humans; Lysergic Acid Diethylamide; Psilocybin; Research Subjects | 2007 |
Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.
Topics: Adult; Bufotenin; Case-Control Studies; Chromatography, Liquid; Female; Forensic Toxicology; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psilocybin; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Solid Phase Extraction; Specimen Handling; Spectrometry, Mass, Electrospray Ionization | 2013 |
Psychedelics and mental health: a population study.
Topics: Adolescent; Adult; Data Collection; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Mental Health; Mescaline; Middle Aged; Odds Ratio; Psilocybin; Risk Factors; United States | 2013 |
Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
Topics: Adult; Australia; Behavior, Addictive; Drug Users; Europe; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Male; N,N-Dimethyltryptamine; Prevalence; Psilocybin; Substance-Related Disorders; United Kingdom; United States; Young Adult | 2014 |
High hopes.
Topics: Affect; Clinical Trials, Phase III as Topic; Hallucinogens; History, 20th Century; Humans; Lysergic Acid Diethylamide; Psilocybin | 2014 |
Analysis of psilocin, bufotenine and LSD in hair.
Topics: Bufotenin; Chromatography, Liquid; Hair; Humans; Limit of Detection; Lysergic Acid Diethylamide; Psilocybin; Solid Phase Extraction; Tandem Mass Spectrometry | 2015 |
Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential.
Topics: Biomedical Research; Drug and Narcotic Control; Drug Repositioning; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; United Kingdom | 2015 |
Lysergic Acid Diethylamide and Psilocybin Revisited.
Topics: Affect; Amygdala; Animals; Female; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Male; Psilocybin; Reflex, Startle; Sensory Gating | 2015 |
Psilocybin: Psychotherapy or drug?
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Psychotherapy | 2016 |
Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Psychotherapy | 2016 |
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.
Topics: Brain; Brain Mapping; Consciousness; Hallucinogens; Healthy Volunteers; Humans; Ketamine; Lysergic Acid Diethylamide; Magnetoencephalography; Psilocybin; Surveys and Questionnaires | 2017 |
LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.
Topics: Adult; Denmark; Female; Follow-Up Studies; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Psilocybin; Retrospective Studies; Risk | 2017 |
Psychedelic use and intimate partner violence: The role of emotion regulation.
Topics: Adolescent; Adult; Agaricales; Aged; Emotions; Female; Hallucinogens; Humans; Intimate Partner Violence; Lysergic Acid Diethylamide; Male; Middle Aged; Psilocybin; Sex Factors; Surveys and Questionnaires; Young Adult | 2018 |
Psychedelics and Personality.
Topics: Anxiety Disorders; Banisteriopsis; Clinical Trials as Topic; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; N,N-Dimethyltryptamine; Personality; Plant Preparations; Psilocybin; Receptor, Serotonin, 5-HT2A; Substance-Related Disorders | 2018 |
Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.
Topics: Adolescent; Adult; Agaricales; Age Distribution; Aged; Aged, 80 and over; Child; Child, Preschool; Emergency Service, Hospital; Female; Hallucinogens; Humans; Infant; Lysergic Acid Diethylamide; Male; Middle Aged; Poison Control Centers; Psilocybin; Retrospective Studies; United States; Young Adult | 2018 |
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
Topics: Adult; Anxiety; Creativity; Depression; Dose-Response Relationship, Drug; Emotions; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Health; Perception; Personality; Psilocybin; Surveys and Questionnaires | 2019 |
Psychedelic medicine: The biology underlying the persisting psychedelic effects.
Topics: Animals; Banisteriopsis; Cognition; Consciousness; Depression; Diet; Hallucinogens; Humans; Life Style; Lysergic Acid Diethylamide; Microbiota; Models, Biological; Psilocybin; Sleep | 2019 |
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
Topics: Adult; Banisteriopsis; Emotions; Fear; Female; Hallucinogens; Humans; Intelligence; Internet; Lysergic Acid Diethylamide; Male; Middle Aged; N,N-Dimethyltryptamine; Psilocybin; Psychometrics; Religion; Surveys and Questionnaires; Young Adult | 2019 |
Motives and Side-Effects of Microdosing With Psychedelics Among Users.
Topics: Adult; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Motivation; Performance-Enhancing Substances; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires | 2019 |
Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
Topics: Adult; Brain Waves; Connectome; Excitatory Amino Acid Antagonists; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Machine Learning; Magnetoencephalography; Nerve Net; Psilocybin; Receptors, N-Methyl-D-Aspartate; Serotonin 5-HT2 Receptor Agonists | 2019 |
Psychedelic microdosing benefits and challenges: an empirical codebook.
Topics: Adolescent; Adult; Affect; Anxiety; Arousal; Attention; Clinical Trials, Phase I as Topic; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Grounded Theory; Guideline Adherence; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psilocybin; Retrospective Studies; Risk Assessment | 2019 |
Microdosing psychedelics: Motivations, subjective effects and harm reduction.
Topics: Adult; Anxiety; Depression; Dose-Response Relationship, Drug; Female; Hallucinogens; Harm Reduction; Humans; Lysergic Acid Diethylamide; Male; Mental Health; Middle Aged; Motivation; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2020 |
Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.
Topics: Adult; Affect; Arousal; Awareness; Clinical Trials, Phase I as Topic; Consumer Behavior; Culture; Female; Hallucinogens; Humans; Interpersonal Relations; Lysergic Acid Diethylamide; Male; Psilocybin; Self Administration; Social Media; Video Recording | 2019 |
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
Topics: Adolescent; Adult; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2020 |
Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.
Topics: Animals; Disease Models, Animal; Female; Hallucinogens; Lysergic Acid Diethylamide; Male; Psilocybin; Rats; Recurrence | 2020 |
Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Substance-Related Disorders | 2020 |
Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Emotions; Empathy; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Narcissism; Psilocybin; Retrospective Studies; Serotonin Receptor Agonists; Thinking; Young Adult | 2020 |
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
Topics: Cerebral Cortex; Consciousness; Default Mode Network; Hallucinogens; Humans; Lysergic Acid Diethylamide; Magnetic Resonance Imaging; Psilocybin | 2020 |
Psychedelic medicine: safety and ethical concerns.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Psilocybin; Psychopharmacology | 2020 |
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.
Topics: Adaptation, Psychological; Adult; Avoidance Learning; Cross-Sectional Studies; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mysticism; Psilocybin; Psychometrics; Reproducibility of Results; Surveys and Questionnaires | 2021 |
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.
Topics: Adult; Affect; Anxiety; Dose-Response Relationship, Drug; Emotions; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Health; Middle Aged; Motivation; Outcome Assessment, Health Care; Placebo Effect; Psilocybin; Quality of Life | 2021 |
How ecstasy and psilocybin are shaking up psychiatry.
Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Drug Prescriptions; Efficiency; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Neuronal Plasticity; Niacin; Psilocybin; Psychiatry; Psychotherapy; Rumination, Cognitive; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic | 2021 |
Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Narration; Pharmaceutical Preparations; Psilocybin | 2021 |
Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Intention; Lysergic Acid Diethylamide; Male; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2022 |
Associations between lifetime classic psychedelic use and markers of physical health.
Topics: Adult; Body Mass Index; Drug Users; Female; Hallucinogens; Health Status; Heart Diseases; Humans; Lysergic Acid Diethylamide; Male; Mental Health; Neoplasms; Psilocybin; Self Report; Substance-Related Disorders; Surveys and Questionnaires; United States | 2021 |
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Drug Evaluation, Preclinical; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Psilocybin; Serotonin 5-HT2 Receptor Agonists | 2021 |
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
Topics: Australia; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Health; Psilocybin | 2021 |
The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Health; Pharmaceutical Preparations; Psilocybin | 2021 |
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
Topics: Adult; Attitude; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Health Services; Psilocybin | 2022 |
Pharmacologic Similarities and Differences Among Hallucinogens.
Topics: Biogenic Monoamines; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Substance-Related Disorders; Tryptamines | 2021 |
Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity.
Topics: Animals; Electroencephalography; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Rats | 2021 |
Dosing Psychedelics and MDMA.
Topics: Hallucinogens; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Psilocybin | 2022 |
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.
Topics: Adolescent; Adult; Anxiety; Cognition; Cross-Sectional Studies; Depression; Female; Hallucinogens; Humans; International Cooperation; Lysergic Acid Diethylamide; Male; Mental Health; Middle Aged; Motivation; Psilocybin; Surveys and Questionnaires; Young Adult | 2021 |
Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Psychiatry; Substance-Related Disorders | 2022 |
Models of psychedelic drug action: modulation of cortical-subcortical circuits.
Topics: Animals; Brain; Cerebral Cortex; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
Topics: Adolescent; Adult; Aged; Female; Hallucinogens; Health Surveys; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress, Psychological; Substance-Related Disorders; Suicidal Ideation; United States; Young Adult | 2022 |
Analysis of recreational psychedelic substance use experiences classified by substance.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Substance-Related Disorders | 2022 |
Shedding Light on Classic Psychedelics and Self-Harm.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Self-Injurious Behavior | 2022 |
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.
Topics: Diagnostic and Statistical Manual of Mental Disorders; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Structure-based discovery of nonhallucinogenic psychedelic analogs.
Topics: Animals; Antidepressive Agents; Arrestin; Binding Sites; Crystallography, X-Ray; Drug Design; Hallucinations; Hallucinogens; Heterocyclic Compounds, 4 or More Rings; Humans; Ligands; Lisuride; Lysergic Acid Diethylamide; Mice; Protein Conformation; Psilocybin; Receptor, Serotonin, 5-HT2A; Serotonin; Signal Transduction; Structure-Activity Relationship | 2022 |
Toward the "helioscope" hypothesis of psychedelic therapy.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Effects of the 5-HT
Topics: Animals; Depression; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Mice; Phenethylamines; Piperidines; Psilocybin; Rats; Receptor, Serotonin, 5-HT2A; Rodentia; Self Stimulation; Serotonin; Tryptamines | 2022 |
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Prospective Studies; Psilocybin; Retrospective Studies; Surveys and Questionnaires | 2022 |
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.
Topics: Antidepressive Agents; Depressive Disorder, Major; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Surveys and Questionnaires | 2022 |
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.
Topics: Antidepressive Agents; Humans; Lysergic Acid Diethylamide; Psilocybin; Randomized Controlled Trials as Topic | 2022 |
Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.
Topics: Brain; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Serotonin Agents | 2022 |
Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.
Topics: Cannabis; COVID-19; Hallucinogens; Humans; Lysergic Acid Diethylamide; Pandemics; Poland; Psilocybin | 2022 |
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.
Topics: Adult; Hallucinogens; Hematologic Neoplasms; Humans; Lysergic Acid Diethylamide; Neoplasms; Phenethylamines; Psilocybin | 2022 |
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.
Topics: Banisteriopsis; Hallucinogens; Humans; Lysergic Acid Diethylamide; N,N-Dimethyltryptamine; Phobic Disorders; Psilocybin | 2022 |
Psychedelic drugs take on depression.
Topics: Depression; Hallucinogens; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.
Topics: Brain; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists | 2022 |
Psilocybin: a revolution in psychedelic medicines in the US?
Topics: Emotions; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Use of psychedelics in the Czech Republic: results of recent population surveys.
Topics: Adult; Cannabis; Cross-Sectional Studies; Czech Republic; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Male; Psilocybin; Substance-Related Disorders | 2022 |
Is good science leading the way in the therapeutic use of psychedelic drugs?
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Set and setting in microdosing: an oft-overlooked principle.
Topics: Hallucinogens; Lysergic Acid Diethylamide; Problem Solving; Psilocybin | 2022 |
Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.
Topics: Adolescent; Child; Cross-Sectional Studies; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Suicidal Ideation | 2022 |
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.
Topics: Animals; Controlled Substances; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders; United States | 2023 |
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Psilocybin | 2023 |
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.
Topics: Agaricales; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Surveys and Questionnaires | 2023 |
Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.
Topics: Antidepressive Agents; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2023 |
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.
Topics: Allosteric Regulation; Animals; Antidepressive Agents; Binding Sites; Brain-Derived Neurotrophic Factor; Embryo, Mammalian; Female; Hallucinogens; HEK293 Cells; Humans; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred C57BL; Molecular Dynamics Simulation; Neuronal Plasticity; Neurons; Psilocybin; Receptor, trkB; Signal Transduction | 2023 |
Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.
Topics: Female; Hallucinogens; Humans; Longitudinal Studies; Lysergic Acid Diethylamide; Male; Prevalence; Psilocybin; United States; Young Adult | 2023 |
No trip needed for psychedelics to lift mood?
Topics: Animals; Antidepressive Agents; Brain; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mice; Psilocybin; Receptor, Serotonin, 5-HT2A; Receptor, trkB; Serotonin 5-HT2 Receptor Antagonists | 2023 |
Psychedelic treatment for anorexia.
Topics: Anorexia; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin | 2023 |
Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats.
Topics: Animals; Antidepressive Agents; Hallucinogens; Lysergic Acid Diethylamide; Male; Psilocybin; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology | 2023 |